Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive

Contraception

Volumn 66, Issue 6, 2002, Pages 393-399

  Hendrix, Susan L ^a   Alexander, Nancy J ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Organon Pharmaceuticals   (United States)

Author keywords

Desogestrel; Dysmenorrhea; Ethinyl estradiol; MDQ; Mircette ; Oral contraceptives; Prostaglandin

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ACNE; ADOLESCENT; ADULT; ANXIETY; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DOCUMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LONELINESS; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICAL ASSESSMENT; MEDICAL RECORD; MENSTRUATION; MULTICENTER STUDY; MYALGIA; NAUSEA; PAIN THRESHOLD; PHARYNGITIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; WEIGHT GAIN;

ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DOUBLE-BLIND METHOD; DYSMENORRHEA; ETHINYL ESTRADIOL; FEMALE; HEADACHE; HUMANS; PLACEBOS; TREATMENT OUTCOME; UNITED STATES;

EID: 0142110328     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00414-6     Document Type: Article

References (19)

1. Speroff L., Glass R.H., Kase N.G. Menstrual disorders. Clinical gynecologic endocrinology, and infertility. 6th edn. 1999;557-573 Lippincott Williams, Wilkins, Philadelphia, PA.
2. Avant R.F. Dysmenorrhea. Prim Care. 15:1988;549-559.
3. Lammers P., op ten Berg M. Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol. Acta Obstet Gynecol Scand. 70:1991;497-500.
4. Teichmann A.T., Brill K., Albring M., Schnitker J., Wojtynek P., Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol. 9:1995;299-305.
5. Spona J., Elstein M., Feichtinger W., et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception. 54:1996;71-77.
6. Killick S.R., Fitzgerald C., Davis A. Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel effects of low estrogen doses during the hormone-free interval . Am J Obstet Gynecol. 179:1998;S18-S24.
7. Milsom I., Andersch B. Effect of various oral contraceptive combinations on dysmenorrhea. Gynecol Obstet Invest. 17:1984;284-292.
8. Moos R.H. The development of a menstrual distress questionnaire. Psychosom Med. 30:1968;853-867.
9. Sanders S.A., Graham C.A., Bass J.L., Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 64:2001;51-58.
10. Dawood M.Y. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand Suppl. 138:1986;7-10.
11. Dawood M.Y. Dysmenorrhea. J Reprod Med. 30:1985;154-167.
12. Åkerlund M. Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl. 87:1979;27-32.
13. Dawood M.Y. Dysmenorrhea. Clin Obstet Gynecol. 33:1990;168-178.
14. Mishell D.R. Jr. Noncontraceptive benefits of oral contraceptives. J Reprod Med. 38:(Suppl 12):1993;1021-1029.
15. Chan W.Y., Dawood M.Y., Fuchs F. Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am J Med. 70:1981;535-541.
16. Ekström P., Juchnicka E., Laudanski T., Åkerlund M. Effect of an oral contraceptive in primary dysmenorrhea - changes in uterine activity and reactivity to agonists. Contraception. 40:1989;39-47.
17. Ulstein M., Svendsen E., Steier A., et al. Clinical experience with a triphasic oral contraceptive. Acta Obstet Gynecol Scand. 63:1984;233-236.
18. Privrel T., Daubenfeld O. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol). Br J Clin Pract. 42:1988;292-298.
19. Hoppe G. Gestoden, an innovative progestogen. Contraception. 37:1988;493-501.